“Patent Thickets” are Anti-Competitive and Lead to Higher Drug Costs

Patent thickets are a drug manufacturer’s strategy that keeps competitor products off the market and reduces PBMs’ ability to negotiate savings.

Learn More >

Nationwide, More Independent Pharmacies Opened in 2020

During the COVID-19 pandemic, the net number of retail independent pharmacies nationwide increased.

Read More >

Exploring the Impact of the Robinson-Patman Act

JC Scott sits down with Ross Margulies, a Partner with special expertise in Medicare and Medicaid law at Foley Hoag LLP. JC and Ross discuss the antitrust litigations that have shaped the drug supply chain.

Listen Now >

Pharmacy Benefit Managers Prepared for Introduction of Aduhelm

The Food and Drug Administration (FDA) has approved Aduhelm to treat Alzheimer’s disease. Learn the perspective of America’s pharmacy benefit managers, PBMs, which are positioned squarely at the intersection of access and affordability for patients.

Read More

The Rebate Rule Would Increase Medicare Part D premiums 25%

Medicare beneficiaries appreciate the Biden Administration’s decision to delay the prescription drug rebate rule.

Learn More

PCMA Latest News

PCMA Smart Briefs

PBMs are working to help 266 million patients get the prescriptions they need during the pandemic.
Better access. Better Cost. Better Health.

PCMA’s Commitment to Diversity, Inclusion and Equity

PCMA believes that organizational and employee success require a diverse, equitable, and inclusive workforce and a culture that embraces and encourages different perspectives. We recognize the inherent value in employing a workforce with a range of experiences and it is our commitment to embrace every person’s uniqueness and to provide a professional work environment where everyone is welcome and treated with dignity and respect.

PCMA has signed on to the CEO Action for Diversity & Inclusion™ pledge. Read more here.

Join the Conversation

Stay Connected with PCMA!